SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-459037"
 

Sökning: id:"swepub:oai:DiVA.org:uu-459037" > Nonvaccine human pa...

Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment

Carlander, Christina (författare)
Karolinska Institutet,Uppsala universitet,Centrum för klinisk forskning, Västerås,Karolinska Inst, Dept Med Huddinge, Unit Infect Dis, Stockholm, Sweden.
Lagheden, Camilla (författare)
Karolinska Inst, Dept Lab Med, Div Clin Pathol, Stockholm, Sweden.
Eklund, Carina (författare)
Karolinska Inst, Dept Lab Med, Div Clin Pathol, Stockholm, Sweden.
visa fler...
Kleppe, Sara Nordqvist (författare)
Karolinska Institutet
Dzabic, Mensur (författare)
Karolinska Inst, Dept Lab Med, Div Clin Pathol, Stockholm, Sweden.
Wagner, Philippe (författare)
Uppsala universitet,Centrum för klinisk forskning, Västerås
Sparen, Pär (författare)
Karolinska Institutet
Dillner, Joakim (författare)
Karolinska Institutet
visa färre...
 (creator_code:org_t)
Wolters Kluwer, 2021
2021
Engelska.
Ingår i: AIDS. - : Wolters Kluwer. - 0269-9370 .- 1473-5571. ; 35:14, s. 2367-2374
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Objective: The aim of this study was to assess failure after treatment of high-grade cervical intraepithelial neoplasia (CIN2+) by HIV status and human papillomavirus (HPV) type.Design: A population-based register study.Methods: The Swedish National HIV Registry, the Swedish Population Registry and the Swedish National Cervical Screening Registry were linked to identify all women in Stockholm and Gothenburg counties (Sweden) living with HIV and diagnosed with CIN2+ sometime between 1983 and 2014 (n = 179). HIV-negative controls with CIN2+, were matched (2 : 1) for country of birth. CIN2+ biopsies were retrieved from biobanks and genotyped. Absolute risk and adjusted odds ratios (adjOR) of treatment failure by HIV status given HPV type (HPV16/18 vs. non-HPV16/18) were calculated.Results: HPV16 (32%) and HPV35 (24%) dominated in women living with HIV (WLWH) with failure, HPV35 mainly in women born in sub-Saharan Africa (67%). The absolute risk of failure in women with HPV16/18 was 26% [95% confidence interval (95% CI) 14-44] in WLWH and 12% in HIV-negative (95% CI 7-19). The absolute risk of failure in women with non-HPV16/18 was 20% (95% CI 12-31) in WLWH and 5% in HIV-negative (95% CI 2-11). WLWH with non-HPV16/18 were six times more likely to fail than HIV-negative (adjOR 6.1, 95% CI 2.0-18.6).Conclusion: HPV35, not included in current HPV vaccines, was the second most common type in WLWH with failure. WLWH with non-HPV16/18 were six times more likely to fail than HIV-negative. This could have implications for surveillance and vaccination post CIN2+ treatment, particularly in WLWH from sub-Saharan Africa.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Infectious Medicine (hsv//eng)

Nyckelord

cervical intraepithelial lesions
excision treatment outcome
HIV
human papillomavirus
treatment

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

  • AIDS (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy